NAMPT and hepatocellular carcinoma: These data are in concordance with these of Ninomiya et al., (2011) and Liang et al., (2018) who found that visfatin level is significantly higher in HCC patients compared to control group, and that it induces HCC cell migration via upregulation of miR-21.